Recall: Anagrelide
Jun. 2022Pharmacy Updates
Teva has recalled one lot of Anagrelide 0.5 mg capsules. Anagrelide is used to treat conditions that cause a patient’s platelet count to be too high. The drug is being recalled because testing showed that it took longer than expected for the medication to dissolve in the body. Read the full text of the Anagrelide recall.
Recent Announcements
CME Webinar: American Foundation for Suicide Prevention’s ‘Talk Saves Lives’ Program
Please join us on Tuesday, April 28, from noon to 1 p.m. for “Talk Saves Lives: An Introduction to Suicide Prevention.” This live, CME-accredited webinar is the American Foundation for Suicide Prevention’s flagship suicide prevention education program. It covers the scope of this leading cause of death, warning signs and risk factors for suicide, and strategies to prevent it.Feb. 2026Education/Webinars
Training Webinar: Conversio Health COPD Management Program
Please join us for a live training webinar by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.Jan. 2026Education/Webinars
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Jan. 2026Important Notices